OLORINAB
UNII 581F7DFA9B

Substance Identification & Data

This profile provides standardized clinical and technical data for Olorinab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 581F7DFA9B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1268881-20-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

581F7DFA9B

CAS Registry Number

1268881-20-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OLORINAB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H23N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ACSQLTBPYZSGBA-GMXVVIOVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C166825

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

60164925

Unique identification number in the NCBI database of chemical substances.

INN ID

10809

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-16

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12(c3c(C[C@@]1(C2)[H])c(nn3-c4ncc[n+](c4)[O-])C(N[C@H](CO)C(C)(C)C)=O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Olorinab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OLORINAB

Common Names & Synonyms

OLORINAB [INN]

OLORINAB [USAN]

OLORINAB [WHO-DD]

Systematic Nomenclature

(1AS,5AS)-2-(4-OXY-PYRAZIN-2-YL)-1A,2,5,5A-TETRAHYDRO-1H-2,3-DIAZA-CYCLOPROPA(A)PENTALENE-4-CARBOXYLIC ACID ((S)-1-HYDROXYMETHYL-2,2-DIMETHYL-PROPYL)-AMIDE

SYS

(4AS,5AS)-N-((2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL)-1-(4-OXIDOPYRAZIN-2-YL)-4,4A,5,5A-TETRAHYDRO-1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE

SYS

1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE, 4,4A,5,5A-TETRAHYDRO-N-((1S)-1-(HYDROXYMETHYL)-2,2-DIMETHYLPROPYL)-1-(4-OXIDO-2-PYRAZINYL)-, (4AS,5AS)-

SYS